---

 

Corporate Executive

Director's Profile & Corporate Disclosure of Oriscon Biotech India Private Limited

BOARD OF DIRECTORS

P. R. Shrivastava                  Director ( 1st )  K. Kumar                              Director ( 2nd )	Chairman & Managing Director Joint Director
Dr. A. K. Singh                      Director	Human Resources Director
J. Sah                                    Director	Investment committee Director
A.C. Verma                           Director	Audit Committee Director
M. K. Thakur                        Director	Legal Affairs Director
M. Kumar                             Director	Welfare committee Director
Dr. B. K. Gupta                     Director	Product Research Director
K. Mishra                             Director	Corporate Affairs Director
U. K. Thakur                        Outside Director	Non executive Independent Director
T. Kumar                              Outside Director	Audit Committee Member

COMPANY SECRETARY  :  M/S Arun Associates, New Delhi      

BANKERS  :    (1)   Punjab National Bank     (2)  AXIS  BANK

AUDITORS  :  M/S Jha Shailendra & Associates , Chartered Accountants 

                         MR. SHAILENDRA KUMAR JHA (FCA ).        

    

---

 "We  are  a  company  registered  under  the  Indian Companies Act,1956 in  the   year  2006  at  New Delhi . At  Oriscon  Biotech (I)  Pvt Ltd our  philosophy  is   to  provide economically  priced  good  quality Pharmaceutical Products to   the  humankind  at  large.  We also believe   that there should  be no compromise  on  the  health  of  a  human   being. Our vision  is  to become  a  significant  major  Pharmaceutical   Company  in India  by providing   good quality  &   affordable  economical medicine for  the  treatment of   all   types of   life   threatening   disease "

---

In the year 2010-11 your Company has declared the dividend of 14% (inclusive of dividend tax). The right shares issued during March ( 2010 - 11 ) also qualify for full year's dividend. The Company's financial results for the financial year ended 31^st March 2011 are summarised below: 

The authorised capital of the company has increased from Rs.40,00,000/-( Rupees Forty Lacs only) to Rs.2,00,00,000/- (Rupees Two crore only) by creation of 16,00,000 (Sixteen Lacs) New equity shares of Rs.10/- (Rupees Ten only) each. Consequently, Clause V of the Memorandum of Association and Article 3 (a) of the Articles of Association of the Company is proposed to be altered.

A Copy of Memorandum and Articles of Association of the Company together with the proposed alteration will be made available for inspection by the Members of the Company at its Registered office between 11:00 a.m. and 1:00 p.m. on any working day of the Company till the date of Annual General Meeting.

In terms of the provisions of Section (s) 16, 31and 94 consent of the Members is required for any alteration in Memorandum and Articles of Association of the Company. The Board recommends the Resolutions for your approval.

Under section 293(1)(d) of the Companies Act, 1956, the Board of Directors cannot except with the consent of the Company borrow moneys apart from temporary loans obtained from the Company's bankers in the ordinary course of business in excess of the aggregate of paid-up capital and free reserves of the Company, that is to say, reserves not set apart for any specific purpose.

The members of the Company at the Extra-ordinary General meeting held on April 20, 2010 by Special resolution authorised Board of Directors of the Company to borrow up to a limit of Rs. 2 crores. In view of increased volume of business envisaged in the forthcoming months, it is proposed to authorise the Board to borrow up to Rs2 crores and for this purpose approval of the members is sought under Section 293(1)(d) of the Act.

---

---